Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-24-131061
Filing Date
2024-12-23
Accepted
2024-12-23 07:32:39
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 7413
2 EXHIBIT 99.1 tm2431704d1_ex99-1.htm EX-99.1 3717
  Complete submission text file 0001104659-24-131061.txt   13033
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filed by) CIK: 0000310158 (see all company filings)

IRS No.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SCHEDULE 13G
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 6600 DUMBARTON CIRCLE FREMONT CA 94555
Business Address 6600 DUMBARTON CIRCLE FREMONT CA 94555 650-752-1300
Personalis, Inc. (Subject) CIK: 0001527753 (see all company filings)

IRS No.: 275411038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-91398 | Film No.: 241569877
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)